Michael Sidler is a Co-Founder and General Partner at redalpine, a pan-European venture capital firm established in Zurich in 2006, with additional offices in Berlin, London, and a presence in San Francisco. Sidler has extensive board and advisory roles across several innovative companies, including ExpressionEdits, Apoha, Better Dairy, Maximon, ImmunOs Therapeutics AG, Memo Therapeutics AG, and Araris Biotech AG, where significant advancements in antibody-drug conjugate technology have been achieved. Additionally, Sidler has a strong academic background, holding a PhD in Plant Molecular Biology from the University of Zurich and having completed an Executive Program at Singularity University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices